PRODUCTS

Product Pipeline
Transplant / Hematology
MOZOBIL PBSC
MOZOBIL Tissue Repair
HIV
AMD070
CCR5
Oncology
CXCR4 Inhibitors
Licensees
FOSRENOL
NX473
Licensing Opportunities
Patents

Product Pipeline

Additional Products

FOSRENOL™

Sold global patents to Shire Pharmaceuticals for up to U.S.$31M and received U.S.$19M in milestone payments to date.

NX473

Licensed NX473 to NeoRx Corporation for up to U.S.$13M in milestones and up to 15% in royalty payments.